US Drug Recall Register
Class I · High risk Terminated Initiated Apr 20, 2020 (6 years ago)

Ketorolac Tromethamine Injection

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter - found in reserve sample vials at the firm.

What was recalled

Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL Single Dose Vials per tray (NDC 63323-162-01); For IM or IV use, Rx only, Fresenius Kabi, Lake Zurich, IL 60047.

Recalling firm
Fresenius Kabi USA, LLC
NDC code
63323-162-00
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1296-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ketorolac recalls

See all
Class II · Moderate risk Ongoing

Dexamethasone Moxifloxacin Ketorolac

Reason Presence of particulate matter - Glass like particles.

Imprimis NJOF, LLC NDC 71384-513-01 D-0250-2026
Class II · Moderate risk Ongoing

R.E.C.K.

Reason Presence of Particulate Matter

QuVa Pharma, Inc. NDC 70092-1433-50 D-0113-2026
Class II · Moderate risk Ongoing

Ketorolac Tromethamine Injection

Reason Presence of Particulate Matter: Particulate matter identified as glass

Aspiro Pharma Limited NDC 31722-307-25 D-0036-2026
Class II · Moderate risk Ongoing

Ketorolac Tromethamine Ophthalmic Solution

Reason Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns

Apotex Corp. NDC 60505-1003-1 D-0677-2025